179 related articles for article (PubMed ID: 34516350)
41. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
42. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis.
Wang J; Liu Y; Cai H; Jiang H; Li W; Shi Y
Bioengineered; 2021 Dec; 12(1):6264-6274. PubMed ID: 34499007
[TBL] [Abstract][Full Text] [Related]
43. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
Tyszka-Czochara M; Lasota M; Majka M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
45. IRTKS contributes to the malignant progression of cervical cancer cells.
Zhang Y; Yi F; Zhang X; Song J; Cai J; Lai J; Song F
Med Oncol; 2024 Jun; 41(7):174. PubMed ID: 38869721
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
[TBL] [Abstract][Full Text] [Related]
47. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
48. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling.
Li H; Zhang W; Yan M; Qiu J; Chen J; Sun X; Chen X; Song L; Zhang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):33. PubMed ID: 30678687
[TBL] [Abstract][Full Text] [Related]
49. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
50. By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells.
Li H; Wang J; Xu F; Wang L; Sun G; Wang J; Yang Y
Future Oncol; 2019 May; 15(14):1577-1591. PubMed ID: 30859853
[No Abstract] [Full Text] [Related]
51. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
52. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
54. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.
Wang J; Ou J; Guo Y; Dai T; Li X; Liu J; Xia M; Liu L; He M
Br J Cancer; 2014 Jul; 111(1):112-24. PubMed ID: 24874481
[TBL] [Abstract][Full Text] [Related]
55. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Chen X; Lan K; Liu Q; Yang X; Wang H
Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
[TBL] [Abstract][Full Text] [Related]
56. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
57. Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.
Liu X; Wang D; Liu H; Feng Y; Zhu T; Zhang L; Zhu B; Zhang Y
Cell Cycle; 2014; 13(11):1702-7. PubMed ID: 24675891
[TBL] [Abstract][Full Text] [Related]
58. Defective expression of polarity protein Par3 promotes cervical tumorigenesis and metastasis.
Zheng JH; Jiao SJ; Na L; Zheng SQ; Ma ZH; Wang SW; Aili A; Hasim A
Eur J Gynaecol Oncol; 2017; 38(2):199-206. PubMed ID: 29953780
[TBL] [Abstract][Full Text] [Related]
59. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
[TBL] [Abstract][Full Text] [Related]
60. MiR-377-3p inhibits cell metastasis and epithelial-mesenchymal transition in cervical carcinoma through targeting SGK3.
Zhang XY; Dong XM; Wang FP
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4687-4696. PubMed ID: 32432732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
